Abscess of mediastinum

J10_ABSCMEDIASTINUM

Lung Abscess: Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 J85.3
  • Hospital discharge: ICD-9 5131
  • Cause of death: ICD-10 J85.3
  • Cause of death: ICD-9 5131

2 out of 7 registries used, show all original rules.

62

4. Check minimum number of events

None

62

5. Include endpoints

None

62

6. Filter based on genotype QC (FinnGen only)

62

Control definitions (FinnGen only)

Control exclude
J10_NECROTIC

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J85
Name in latin
Abscessus mediastini

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 468 143 320
Only index persons 353 110 243
Unadjusted period prevalence (%)
Whole population 0.01 0.00 0.01
Only index persons 0.01 0.00 0.01
Median age at first event (years)
Whole population 62.93 66.74 61.28
Only index persons 61.87 64.58 60.65

-FinnGen-

Key figures

All Female Male
Number of individuals 62 22 40
Unadjusted period prevalence (%) 0.01 0.01 0.02
Median age at first event (years) 65.85 61.50 68.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
60
Matched controls
599
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J85.3
ICD-10 Finland
Abscess of mediastinum
+∞
76.3
56
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.9
8.6
15
15
J98.5
ICD-10 Finland
Diseases of mediastinum, not elsewhere classified
+∞
8.5
8
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
7.8
8.3
20
36
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.8
7.8
25
66
FWC00
NOMESCO Finland
Reoperation for deep infection in surgery of heart and major thoracic vessels
90.9
7.6
8
*
ENA32
NOMESCO Finland
Incision of deep pharyngeal infection
+∞
7.4
7
*
ZXD05
NOMESCO Finland
Urgent procedure
4.6
7.3
34
132
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.3
6.4
15
26
K22.2
ICD-10 Finland
Oesophageal obstruction
+∞
6.4
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
21
61
4.69
7.04
4.3
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
33
154
3.44
5.43
8.8
4.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
37
4.60
5.14
2.2
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
24
5.36
5.00
2.4
2.9
%
0.9
1.5
1.04
11
24
(3019230) Fractional oxyhemoglobin in Venous blood
8
7
12.86
4.93
2.5
1.0
%
68.0
67.2
—
8
7
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
25
106
3.28
4.68
6.4
2.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
8
11.25
4.67
2.6
2.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
8
9.67
3.88
2.0
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
20
82
3.12
3.87
12.2
5.7
mmol/l
1.2
1.1
0.33
20
76
(3012095) Magnesium [Moles/volume] in Serum or Plasma
21
90
3.02
3.76
12.9
3.1
mmol/l
0.8
0.8
0.89
21
85
(3044640) Blood type and Crossmatch panel - Blood
29
149
2.78
3.73
6.8
2.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
12
36
3.89
3.69
1.8
1.8
%
1.8
1.4
—
7
29
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
13
6.88
3.63
1.1
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
34
197
2.61
3.36
7.2
4.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
10
28
4.07
3.35
2.4
3.1
g/l
130.2
127.4
—
10
28
(3000991) Gas panel - Venous blood
14
52
3.19
3.14
21.9
7.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
59
3.03
3.06
2.1
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
5
10.71
3.03
1.4
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
20
93
2.70
3.02
1.9
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
12
42
3.30
2.94
2.7
2.9
g/l
9.7
10.1
0.13
12
36
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
10
6.50
2.76
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
10
6.50
2.76
1.2
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
15
5.11
2.68
1.4
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
15
5.11
2.68
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
11
5.90
2.61
1.2
1.1
—
—
—
0
0
(3012544) pH of Venous blood
14
58
2.83
2.59
4.7
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
11
40
3.13
2.53
7.5
1.9
ng/l
207.5
222.3
0.05
11
35
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
8
6.67
2.41
1.4
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
18
4.24
2.32
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
12
49
2.80
2.26
2.8
2.8
ug/l
3.6
6.5
1.03
12
42
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
25
3.52
2.18
27.5
7.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
29
181
2.13
2.18
15.9
5.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
20
3.81
2.12
1.7
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
39
2.86
2.03
2.0
1.6
g/l
0.8
1.0
—
10
32
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
67
2.41
1.94
2.1
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
17
3.79
1.88
2.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
55
2.47
1.81
1.5
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
13
62
2.39
1.81
2.5
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
8
30
2.91
1.79
1.8
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
18
3.57
1.79
1.0
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
49
2.51
1.75
1.3
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
13
4.08
1.75
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
13
4.08
1.75
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
25
3.02
1.70
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.38
1.70
1.8
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
19
3.38
1.70
2.5
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
31
214
1.90
1.65
15.8
9.4
inr
1.4
1.3
—
6
63
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
20
3.21
1.62
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
13
66
2.23
1.57
2.0
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
16
3.30
1.46
1.4
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
17
99
1.99
1.46
5.1
2.3
mg/l
1.5
1.2
0.35
17
82
(3022313) Gas panel - Capillary blood
9
42
2.33
1.41
11.6
7.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
17
3.10
1.38
1.6
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
34
252
1.77
1.37
16.7
7.5
mmol/l
1.2
1.2
0.28
29
212
(36660697) Celiac disease serology panel - Serum
8
34
2.55
1.35
1.5
1.3
—
—
—
0
0
(3000492) Spirometry study
8
40
2.15
1.17
2.0
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
8
40
2.15
1.17
13.1
7.9
mmol/l
23.0
25.1
—
8
40
(4035726)
9
45
2.17
1.11
2.3
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
36
282
1.66
1.11
5.3
3.3
u/l
66.8
48.3
0.60
31
263
(40768797) Stomach Pathology biopsy report
12
68
1.95
1.10
1.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
47
2.07
1.08
28.9
8.9
mmol/l
24.1
24.5
—
9
47
(3020630) Protein [Mass/volume] in Serum or Plasma
9
48
2.02
1.06
1.9
4.1
g/l
61.3
66.4
—
9
43
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
12
69
1.92
1.05
8.8
3.7
umol/l
4.9
12.9
1.58
12
59
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
85
1.84
1.05
2.4
2.3
e6/l
3.0
0.6
—
7
48
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
22
2.38
1.05
1.0
6.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
54
2.02
1.03
11.6
10.9
—
—
—
0
0
(3020891) Body temperature
6
27
2.35
0.96
6.0
5.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
6
29
2.18
0.92
1.3
3.4
—
55.0
—
0
12
(3024561) Albumin [Mass/volume] in Serum or Plasma
29
223
1.56
0.91
11.4
4.9
g/l
32.3
35.0
1.46
29
210
(3019225) pH of Specimen
8
45
1.89
0.88
6.6
4.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
33
394
0.65
0.84
55.0
20.3
%
14.6
13.8
2.32
33
388
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
32
1.97
0.84
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
26
198
1.54
0.84
2.7
2.1
pmol/l
100.6
93.0
0.37
16
106
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
25
0.00
0.81
0.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
26
0.00
0.80
0.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
27
0.00
0.79
0.0
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
20
145
1.56
0.79
3.0
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
25
191
1.52
0.79
3.4
4.0
e6/l
30.1
47.8
0.43
15
138
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
23
2.27
0.78
2.4
2.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
39
330
1.49
0.73
3.8
3.5
pmol/l
14.8
14.8
0.01
33
297
(3037467) Urinalysis macro (dipstick) panel - Urine
38
321
1.47
0.71
6.3
4.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
20
149
1.51
0.69
3.0
2.8
e6/l
0.1
0.3
2.03
15
111
(3019060) Gas panel - Arterial blood
7
43
1.71
0.69
5.3
3.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
29
1.79
0.65
2.4
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
50
1.69
0.64
1.5
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
30
1.72
0.63
1.6
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
168
0.65
0.61
2.9
4.2
%
24.7
21.6
—
5
80
(4034850)
0
20
0.00
0.61
0.0
21.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
19
0.00
0.61
0.0
2.9
—
14.8
—
0
11
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
23
0.00
0.59
0.0
2.6
—
123.9
—
0
16
(1761868) Lipid panel - Serum or Plasma
11
155
0.65
0.58
2.0
3.2
—
—
—
0
0
(3009343) pH of Capillary blood
9
60
1.58
0.58
11.8
6.4
—
7.4
—
0
7
(3011397) Hemoglobin [Presence] in Urine by Test strip
15
110
1.48
0.55
9.5
4.0
—
—
—
0
0
(3044889) 12 lead EKG panel
29
333
0.76
0.44
7.0
4.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
14
106
1.41
0.44
6.2
6.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.2
—
0.7
—
0
10
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
17
0.00
0.41
0.0
6.1
—
32.9
—
0
12
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
9
67
1.40
0.40
17.1
4.5
u/l
246.0
257.3
—
9
62
(40761535) Cells panel - Urine sediment
5
35
1.47
0.40
8.2
3.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
43
1.44
0.36
2.2
3.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
46
1.34
0.34
2.0
3.3
u/l
25.0
29.2
—
6
39
(3000963) Hemoglobin [Mass/volume] in Blood
48
509
0.75
0.34
59.9
24.0
g/l
121.7
133.7
3.98
48
498
(3024731) MCV [Entitic volume]
48
509
0.75
0.34
59.0
23.8
fl
91.1
90.9
0.09
48
499
(3035941) MCH [Entitic mass]
48
509
0.75
0.34
58.9
23.8
pg
30.0
30.2
0.29
48
499
(40761511) CBC panel - Blood by Automated count
45
480
0.77
0.32
32.8
15.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
142
1.27
0.28
25.7
7.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
18
152
1.26
0.28
3.8
2.0
u/l
172.4
279.5
0.39
18
144
(3026008) Bacteria identified in Urine by Culture
17
143
1.26
0.27
3.3
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
30
271
1.21
0.25
2.8
2.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
10
0.00
0.21
0.0
1.4
—
91.6
—
0
10
(3023103) Potassium [Moles/volume] in Serum or Plasma
46
483
0.82
0.21
50.8
19.4
mmol/l
4.0
4.0
0.79
46
471
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
0.5
—
0
7
(3002256) Pathology report gross observation
7
60
1.19
0.18
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
67
1.22
0.17
1.3
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
46
480
0.84
0.17
48.9
19.5
mmol/l
138.8
139.6
1.23
46
467
(3035350) Ketones [Presence] in Urine by Test strip
26
238
1.16
0.17
6.7
4.0
estimate
0.0
0.0
—
6
53
(3002582) Erythrocytes [#/volume] in Urine
19
170
1.17
0.16
3.0
3.3
e6/l
178.0
410.8
0.24
13
131
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
21
194
1.12
0.11
4.3
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
43
1.18
0.10
3.2
3.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
47
484
0.88
0.09
26.1
11.3
u/l
30.1
25.6
0.37
47
467
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5
60
0.82
0.08
1.8
1.7
nmol/l
449.8
355.8
—
5
52
(3020564) Creatinine [Moles/volume] in Serum or Plasma
47
483
0.89
0.08
45.8
19.6
umol/l
84.9
83.0
0.10
47
483
(3003694) ABO and Rh group [Type] in Blood
12
108
1.14
0.08
2.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
19
179
1.09
0.05
3.7
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
12
130
0.90
0.05
2.4
3.8
—
—
—
0
0
(3013512) EKG study
15
141
1.08
0.04
5.2
4.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
42
421
0.99
0.00
5.4
4.3
mu/l
2.5
2.1
0.80
37
372
(3009542) Hematocrit [Volume Fraction] of Blood
41
411
0.99
0.00
52.5
16.6
%
36.5
39.8
2.59
26
301
(3031040) Bacteria [#/volume] in Urine by Automated count
31
309
1.01
0.00
7.1
4.6
—
436.2
—
0
9
(3029937) Albumin [Presence] in Urine by Test strip
14
135
1.05
0.00
10.9
4.5
estimate
0.0
0.0
—
5
47
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
58
0.85
0.00
4.8
4.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
71
0.98
0.00
1.1
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
24
240
1.00
0.00
8.0
5.2
estimate
0.0
0.0
—
5
49
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
9
0.00
0.00
0.0
5.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
80.4
—
0
9
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
4.2
—
15.6
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
180
1.00
0.00
8.4
4.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
2.1
—
1777.9
—
0
7
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint J10_ABSCMEDIASTINUM and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
J10_ABSCMEDIASTINUM 2.669 [1.97, 3.61] < 0.001
Birth year 0.985 [0.98, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 119 out of 240 males with J10_ABSCMEDIASTINUM died.

Mortality risk

Mortality risk for people of age

years, who have J10_ABSCMEDIASTINUM.

N-year risk Females Males
1 No data 0.478%
5 No data 3.176%
10 No data 7.433%
15 No data 13.659%
20 No data 21.813%

Relationships between endpoints

Index endpoint: J10_ABSCMEDIASTINUM – Abscess of mediastinum

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data